Large CTG repeats trigger p16-dependent premature senescence in myotonic dystrophy type 1 muscle precursor cells

American Journal of Pathology

Volumn 174, Issue 4, 2009, Pages 1435-1442

  Bigot, Anne ^a,b   Klein, Arnaud F ^a,b   Gasnier, Erwan ^a,b   Jacquemin, Virginie ^a,b   Ravassard, Philippe ^c   Butler Browne, Gillian ^a,b   Mouly, Vincent ^a,b   Furling, Denis ^a,b,d  

^a SORBONNE UNIVERSITÉ   (France)

^b INSERM   (France)

^c CNRS   (France)

^d Sorbonne Université   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P16; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DIAGNOSTIC AGENT;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRESS; FETUS; GENE SEQUENCE; GROWTH DISORDER; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE REGENERATION; MUSCLE WEAKNESS; MYOTONIC DYSTROPHY; MYOTONIC DYSTROPHY TYPE 1; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENESCENCE; STEM CELL; TELOMERE; WESTERN BLOTTING; CELL AGING; GENETICS; METABOLISM; MYOBLAST; PATHOLOGY; SKELETAL MUSCLE SATELLITE CELL; TRINUCLEOTIDE REPEAT;

BLOTTING, WESTERN; CELL AGING; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FETUS; HUMANS; IMMUNOHISTOCHEMISTRY; MYOBLASTS; MYOTONIC DYSTROPHY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SATELLITE CELLS, SKELETAL MUSCLE; TELOMERE; TRINUCLEOTIDE REPEATS;

EID: 65349118185     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.080560     Document Type: Article

References (39)

1. Harper PS: Myotonic Dystrophy, ed 3. London, W.B. Saunders, 2004, pp. 17-45
2. Aslanidis C, Jansen G, AmemiyaC, Shutler G, Mahadevan M, Tsilfidis C, Chen C, Alleman J, Wormskamp NG, Vooijs M, Buxton J, Johnson K, Smeets JM, Lennon G, Carrano AV, Korneluk R, Wieringa B, de Jong P: Cloning of the essential myotonic dystrophy region and mapping of the putative defect. Nature 1992, 355:548-551
3. Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, Hunter K, Stanton VP, Thirion JP, Hudson T, Sohn R, Zemelman B, Snell RG, Rundle SA, Crow S, Davies J, Shelbourne P, Buxton J, Jones C, Juvonen V, Johnson K, Harper P, Shaw DJ, Housman D: Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 1992, 68:799-808
4. Fu YH, Pizzuti A, Fenwick Jr RG, King J, Rajnarayan S, Dunne PW, Dubel J, Nasser GA, Ashizawa T, de Jong P, Wieringa B, Korneluk R, Perryman MB, Epstein HF, Caskey CT: An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992, 255:1256-1258
5. Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, Jansen G, Neville C, Narang M, Barcelo J, O'Hoy K, Leblond S, Earl-Macdonald J, de Jong P, Wieringa B, Korneluk R: Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science 1992, 255:1253-1255
6. Hunter A, Tsilfidis C, Mettler G, Jacob P, Mahadevan M, Surh L, Korneluk R: The correlation of age of onset with CTG trinucleotide repeat amplification in myotonic dystrophy. J Med Genet 1992, 29:774-779
7. Tsilfidis C, MacKenzie AE, Mettler G, Barcelo J, Korneluk RG: Correlation between CTG trinucleotide repeat length and frequency of severe congenital myotonic dystrophy. Nat Genet 1992, 1:192-195
8. Paul S, Dansithong W, Kim D, Rossi J, Webster NJ, Comai L, Reddy S: Interaction of muscleblind, CUG-BP1 and hnRNP H proteins in DM1-associated aberrant IR splicing. EMBO J 2006, 25:4271-4283
9. Mankodi A, Takahashi MP, Jiang H, Beck CL, Bowers WJ, Moxley RT, Cannon SC, Thornton CA: Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol Cell 2002, 10:35-44
10. Anvret M, Ahlberg G, Grandell U, Hedberg B, Johnson K, Edstrom L: Larger expansions of the CTG repeat in muscle compared with lymphocytes from patients with myotonic dystrophy. Hum Mol Genet 1993, 2:1397-1400
11. Thornton CA, Johnson K, Moxley III RT: Myotonic dystrophy patients have larger CTG expansions in skeletal muscle than in leukocytes. Ann Neurol 1994, 35:104-107
12. Furling D, Coiffier L, Mouly V, Barbet JP, St Guily JL, Taneja K, Gourdon G, Junien C, Butler-Browne GS: Defective satellite cells in congenital myotonic dystrophy. Hum Mol Genet 2001, 10:2079-2087
13. Vaziri H, West MD, Allsopp RC, Davison TS, Wu YS, Arrowsmith CH, Poirier GG, Benchimol S: ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-trans- lational activation of p53 protein involving poly(ADP-ribose) polymerase. EMBO J 1997, 16:6018-6033
14. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE: Extension of life-span by introduction of telomerase into normal human cells. Science 1998, 279:349-352
15. Di Donna S, Mamchaoui K, Cooper RN, Seigneurin-Venin S, Tremblay J, Butler-Browne GS, Mouly V: Telomerase can extend the prolifera- tive capacity of human myoblasts, but does not lead to their immortalization. Mol Cancer Res 2003, 1:643-653
16. Ramirez RD, Herbert BS, Vaughan MB, Zou Y, Gandia K, Morales CP, Wright WE, Shay JW: Bypass of telomere-dependent replicative senescence (M1) upon overexpression of Cdk4 in normal human epithelial cells. Oncogene 2003, 22:433-444
17. Zhu CH, Mouly V, Cooper RN, Mamchaoui K, Bigot A, Shay JW, Di Santo JP, Butler-Browne GS, Wright WE: Cellular senescence in human myoblasts is overcome by human telomerase reverse tran- scriptase and cyclin-dependent kinase 4: consequences in aging muscle and therapeutic strategies for muscular dystrophies. Aging Cell 2007, 6:515-523
18. Kim WY, Sharpless NE: The regulation of INK4/ARF in cancer and aging. Cell 2006, 127:265-275
19. Jacobs JJ, de Lange T: Significant role for p16INK4a in p53- independent telomere-directed senescence. Curr Biol 2004, 14:2302-2308
20. Campisi J, d'Adda di Fagagna F: Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007, 8:729-740
21. Darbro BW, Lee KM, Nguyen NK, Domann FE, Klingelhutz AJ: Meth- ylation of the p16(INK4a) promoter region in telomerase immortalized human keratinocytes co-cultured with feeder cells. Oncogene 2006, 25:7421-7433
22. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O, Peacocke M, Campisi J: A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995, 92:9363-9367
23. Decary S, Hamida CB, Mouly V, Barbet JP, Hentati F, Butler-Browne GS: Shorter telomeres in dystrophic muscle consistent with extensive regeneration in young children. Neuromuscul Disord 2000, 10: 113-120
24. Robles SJ, Adami GR: Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts. Oncogene 1998, 16:1113-1123
25. Pearson CE, Nichol Edamura K, Cleary JD: Repeat instability: mechanisms of dynamic mutations. Nat Rev Genet 2005, 6:729-742
26. Longhese MP: DNA damage response at functional and dysfunctional telomeres. Genes Dev 2008, 22:125-140
27. von Zglinicki T: Oxidative stress shortens telomeres. Trends Biochem Sci 2002, 27:339-344
28. Oikawa S, Kawanishi S: Site-specific DNA damage at GGG sequence by oxidative stress may accelerate telomere shortening. FEBS Lett 1999, 453:365-368
29. Toscano A, Messina S, Campo GM, Di Leo R, Musumeci O, Rodolico C, Aguennouz M, Annesi G, Messina C, Vita G: Oxidative stress in myotonic dystrophy type 1. Free Radic Res 2005, 39:771-776
30. Usuki F, Ishiura S: Expanded CTG repeats in myotonin protein kinase increase susceptibility to oxidative stress. Neuroreport 1998, 9: 2291-2296
31. Kuyumcu-Martinez NM, Wang GS, Cooper TA: Increased steady- state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC- mediated hyperphosphorylation. Mol Cell 2007, 28:68-78
32. Gopalakrishna R, Jaken S: Protein kinase C signaling and oxidative stress. Free Radic Biol Med 2000, 28:1349-1361
33. Konishi H, Tanaka M, Takemura Y, Matsuzaki H, Ono Y, Kikkawa U, Nishizuka Y: Activation of protein kinase C by tyrosine phosphoryla- tion in response to H2O2. Proc Natl Acad Sci USA 1997, 94:11233-11237
34. Krishnamurthy J, Ramsey MR, Ligon KL, Torrice C, Koh A, Bonner- Weir S, Sharpless NE: p16INK4a induces an age-dependent decline in islet regenerative potential. Nature 2006, 443:453-457
35. Janzen V, Forkert R, Fleming HE, Saito Y, Waring MT, Dombkowski DM, Cheng T, DePinho RA, Sharpless NE, Scadden DT: Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature 2006, 443:421-426
36. Molofsky AV, Slutsky SG, Joseph NM, He S, Pardal R, Krishnamurthy J, Sharpless NE, Morrison SJ: Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing. Nature 2006, 443:448-452
37. Bigot A, Jacquemin V, Debacq-Chainiaux F, Butler-Browne GS, Toussaint O, Furling D, Mouly V: Replicative aging down-regulates the myogenic regulatory factors in human myoblasts. Biol Cell 2008, 100:189-199
38. Borg J, Edstrom L, Butler-Browne GS, Thornell LE: Muscle fibre type composition, motoneuron firing properties, axonal conduction velocity and refractory period for foot extensor motor units in dystrophia myotonica. J Neurol Neurosurg Psychiatry 1987, 50:1036-1044
39. Vattemi G, Tomelleri G, Filosto M, Savio C, Rizzuto N, Tonin P: Expression of late myogenic differentiation markers in sarcoplasmic masses of patients with myotonic dystrophy. Neuropathol Appl Neurobiol 2005, 31:45-52